Sort
40,608 grants matching “prostate cancer”
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$441,943Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2015 · CA
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$441,943Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2018 · CA
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$441,943Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2017 · CA
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$441,943Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2016 · CA
Nanotechnology for targeted therapy and fundamental understanding oftherapeutic resistance in triple negative breast cancer
$441,858Xiaoming He · Univ Of Maryland, College Park · R01 · FY2023 · CA
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer
$441,743Rajvir Dahiya · Northern California Institute/Res/Edu · R01 · FY2014 · CA
Project 1
$441,701James L Mohler · Univ Of North Carolina Chapel Hill · P01 · FY2007 · CA
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma
$441,695Markus Schober · New York University School Of Medicine · R01 · FY2022 · CA
Nanotechnology for targeted therapy and fundamental understanding oftherapeutic resistance in triple negative breast cancer
$441,579Xiaoming He · Univ Of Maryland, College Park · R01 · FY2022 · CA
RESEARCH CORE
$441,565George Stancel · University Of Tx Md Anderson Can Ctr · P60 · FY2008 · MD
Role of TbRIII in Regulating Motility and Invasion
$441,531Gerard C Blobe · Duke University · R01 · FY2010 · CA
Cancer Control Research Training Curriculum
$441,513Gary R Morrow · University Of Rochester · R25 · FY2010 · CA
Regulation of tumor-infiltrating T cells by macrophages
$441,506Xiaopei Huang · Ohio State University · R01 · FY2025 · CA
Multi-Modality Quantitative Imaging for Evaluation of Response to Cancer Therapy
$441,491Michael A Jacobs · Johns Hopkins University · U01 · FY2020 · CA
Acid Ceramidase, Target for Cancer
$441,419Xiang Liu · Sphingogene, Inc. · R41 · FY2009 · CA
Developmental Funds
$441,375Caryn Lerman · University Of Southern California · P30 · FY2023 · CA
Cell Survival Advantage in Cadmium Induced Carcinogenesis
$441,370Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2022 · ES
Beta Camera and Laparoscopic Probe for Surgical Cancer Removal.
$441,362Farhad Daghighian · Intra Medical Imaging, Llc · R44 · FY2010 · CA
Mechanisms of De Novo Methylation in Cancer
$441,298Peter A Jones · University Of Southern California · R37 · FY2011 · CA
Oncolytic reovirus modulation of the cancer cell hypoxic response
$441,245Cathy L Miller · Iowa State University · R15 · FY2017 · CA
Association of inflammatory genes and prostate cancer
$441,199Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2008 · CA
Regulation of tumor-infiltrating T cells by macrophages
$441,166Yiping Yang · Ohio State University · R01 · FY2021 · CA
Cancer in adults following in utero and early life exposure to arsenic
$441,149Craig M Steinmaus · University Of California Berkeley · R01 · FY2015 · ES
Elevated homocysteine in African American Prostate Cancer: Association with Diet and Dietary practices, evaluating its biomarker potential, and characterizing its tumor promoting function
$441,110Arun Sreekumar · Baylor College Of Medicine · R01 · FY2024 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER INTOBAGONIANS
$441,101University Of Pittsburgh At Pittsburgh · R01 · FY2002 · CA